POS-732 A STUDY OF ANGIOTENSIN ii TYPE II RECEPTOR ANTIBODY IN RENAL ALLOGRAFT REJECTION

POS-732 A STUDY OF ANGIOTENSIN ii TYPE II RECEPTOR ANTIBODY IN RENAL ALLOGRAFT REJECTION

Bibliographic Details
Main Authors:	U. Hegde, P. Soni, M. Rajapurkar, S. Gabg, A. Konnur, H. Patel
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921009104

Similar Items

Chronic antibody rejection in renal allograft: An underestimated cause of renal allograft dysfunction
by: Nishika Madireddy, et al.
Published: (2019-01-01)

POS-759 HISTOLOGICAL ANALYSIS OF 3 AND 6 MONTH PROTOCOL BIOPSIES AND OUTCOME SIN ABO INCOMPATIBLE RENAL TRANSPLANTS
by: U. Hegde, et al.
Published: (2021-04-01)

POS-731 PARVOVIRUS DISEASE POST RENAL TRANSPLANT PRESENTING AS REFRACTORY ANEMIA-SINGLE CENTRE EXPERIENCE
by: U. Hegde, et al.
Published: (2021-04-01)

Early eosinophilic antibody-mediated rejection in a renal allograft recipient
by: H Satish, et al.
Published: (2018-01-01)

Treatment of Antibody-Mediated Renal Allograft Rejection: Improving Step by Step
by: Nils Lachmann, et al.
Published: (2017-01-01)

Study of CC chemokine receptor 5 in renal allograft rejection
by: R Ghosh, et al.
Published: (2013-01-01)

POS-396 A RANDOMIZED CONTROL TRIAL OF RITUXIMAB VS MODIFIED PONTICELLI REGIMEN IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY – A PILOT STUDY
by: S. SURESH, et al.
Published: (2021-04-01)

Cincinnati protocol is not suitable for Indian patients with antibody mediated renal allograft rejection
by: Jasmine Sethi, et al.
Published: (2019-01-01)

Allograft renal rejection and chemokine polymorphism
by: Y Gorgi, et al.
Published: (2011-01-01)

Chronic vascular rejection in renal allografts
by: Dennis, Martin John Stewart
Published: (1991)

Commercially available angiotensin II At₂ receptor antibodies are nonspecific.
by: Roman Hafko, et al.
Published: (2013-01-01)

POS-163 A RANDOMIZED CONTROL TRIAL OF RITUXIMAB VERSUS MODIFIED PONTICELLI REGIMEN IN THE TREATMENT OF PRIMARY MEMBRANOUS NEPHROPATHY – A PILOT STUDY
by: S. SURESH, et al.
Published: (2021-04-01)

COMPARISON OF DIFFERENT METHODS OF ANTI-HLA ANTIBODIES DETECTION IN DIAGNOSIS OF ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION
by: E. S. Ivanova, et al.
Published: (2016-11-01)

The angiotensin II type 2 receptor in renal disease
by: Ulrich Otto Wenzel, et al.
Published: (2010-03-01)

A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection
by: G. Hychko, et al.
Published: (2011-04-01)

Renal allograft rejection causing coagulation of urine
by: Sanjay Gogoi, et al.
Published: (2001-01-01)

Renal allograft rejection : in situ studies of tubulitis
by: Robertson, Helen
Published: (2002)

CD103 T cells in renal allograft rejection
by: Wai Keong, Wong
Published: (2003)

Evaluation of Renal Allograft Biopsies for Graft Dysfunction and Relevance of C4d Staining in Antibody Mediated Rejection
by: Clement Wilfred Devadass, et al.
Published: (2016-03-01)

Correction: Commercially Available Angiotensin II AT Receptor Antibodies Are Nonspecific.
by: Roman Hafko, et al.
Published: (2014-01-01)

Renal and urinary levels of endothelial protein C receptor correlate with acute renal allograft rejection.
by: Lionel Lattenist, et al.
Published: (2013-01-01)

B Cell Activating Factor, Renal Allograft Antibody-Mediated Rejection, and Long-Term Outcome
by: Haiyan Xu, et al.
Published: (2018-01-01)

POS-771 ROLE OF INTERLUKIN-6 AMPLIFIER LOOP (IL-6+IL-17) IN CHRONIC ANTIBODY MEDIATED REJECTION IN RENAL ALLOGRAFT RECIPIENT
by: M. SINGH, et al.
Published: (2021-04-01)

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
by: Ye-Ping Ma, et al.
Published: (2020-05-01)

The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
by: Matthew R Weir, et al.
Published: (2001-03-01)

The usefulness of soluble interleukin-2 receptor and other protein markers in renal allograft rejection
by: Kazim, Khalid Abdul Qader
Published: (1999)

Molecular Profiling of Acute and Chronic Rejections of Renal Allografts
by: Hřibová Petra, et al.
Published: (2013-01-01)

Correction: Commercially Available Angiotensin II AT2 Receptor Antibodies Are Nonspecific
by: Roman Hafko, et al.
Published: (2014-01-01)

Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies
by: Meghan H. Pearl, et al.
Published: (2019-04-01)

Renal denervation in a patient with Alport syndrome and rejected renal allograft
by: Narayana Raju, et al.
Published: (2015-12-01)

Studies on angiotensin II receptors
by: Cox, H. M.
Published: (1982)

STUDIES OF CANINE LUNG ALLOGRAFT REJECTION: SIGNIFICANCE OF MHC CLASS II ANTIGENS AND CYTOKINES
by: ZHANG, XI-CHUAN, et al.
Published: (1990)

Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
by: Jakob Mühlbacher, et al.
Published: (2020-04-01)

Detection of class I-related polypeptide-related sequence A (MICA) and angiotensin II type 1 receptor (AT1R) antibodies in antibody mediated rejection in Hong Kong
by: Choi, Chi-wai, et al.
Published: (2014)

The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection
by: Jingming Zhuang, et al.
Published: (2021-02-01)

PCNA in assessment of progression rate of chronic renal allograft rejection
by: Simić-Ogrizović Sanja P., et al.
Published: (2002-01-01)

Renal Allograft Rejection: Noninvasive Ultrasound- and MRI-Based Diagnostics
by: Ulrich Jehn, et al.
Published: (2019-01-01)

Development of a model of chronic rejection in rat renal allografts
by: Graudenz, Marcia Silveira
Published: (1993)

Specific and non-specific suppression of renal allograft rejection in the rat
by: Winearls, Christopher Good
Published: (1978)

Regulation of intratubular T cell adhesion by chemokines in renal allograft rejection
by: Al-Hamidi, Abdulaziz H.
Published: (2008)